Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies

J Neurol Sci. 2021 Nov 15:430:119982. doi: 10.1016/j.jns.2021.119982. Epub 2021 Sep 15.

¹ Department of Neurology, Lewisham and Greenwich NHS Foundation Trust, London, UK; UCL Queen Square Institute of Neurology, London, UK.
² Department of Neurology, Kings College Hospital NHS Foundation Trust, London, UK.
³ Department of Geriatric Medicine, Stroke and Palliative Care, Lewisham and Greenwich NHS Foundation Trust, London, UK.
⁴ Department of Neurology, Lewisham and Greenwich NHS Foundation Trust, London, UK; UCL Queen Square Institute of Neurology, London, UK. Electronic address: eoin.mulroy@nhs.net.

No abstract available

Keywords: Cognition; Limbic encephalitis; Movement disorders; Opsoclonus-myoclonus syndrome; SARS-CoV-2.

MeSH terms